Table 1:
Summary of included studies
| Reference | Location (language) | Participant characteristics | Intervention program | Baduanjin training | Outcome measured | Adverse event; follow-up | |||
|---|---|---|---|---|---|---|---|---|---|
|
|
|
||||||||
| Sample size (attrition rate) | Mean age or age range | Frequency (weekly) | Time (min) | Duration (months) | |||||
| 27 | China (Chinese) | 104 | 40–70 | EG: Baduanjin/CG: Provide education on basic knowledge of hypertension | 3 | 20 | 12 | BP↓, BMI↓, WHR↓ | No |
| 30 | China (Chinese) | 116 | 53.27±10.67 | EG: Baduanjin/CG: no intervention | N | N | 6 | FPG↓ | No |
| 26 | China (Chinese) | 39 | 60–69 | EG: Baduanjin/CG: no intervention | 5 | 40–50 | 3 | Lipid parameters: TG↓, LDL↓, HDL↑ | No |
| 23 | China (Chinese) | 23 | 41±5.61 | EG: Baduanjin/CG: no intervention | 5 | 50–60 | 3 | WC↓, HDL↑, LDL↓ | No |
| 24 | China (Chinese) | 49 | 63±6.35 | EG: Baduanjin/CG: no intervention | 5–7 | 50 | 18 | Lipid parameters: TG↓, TC↓, HDL↓, LDL↓ | No |
| 25 | China (English) | 170 | 50–57 | EG: Baduanjin/CG: no intervention | 3 | 30 | 6 | FGB↓, TG↓, WHR↓, | No |
| 28 | China (Chinese) | 35 | 57.2±5.4 | EG: Baduanjin/CG: no intervention | 6 | 90 | 6 | Lipid parameters: FPG↓, TG↓, HbA1c↓, HDL↑, WHR↓ | No |
| 29 | China (English) | 110 | 20–59 | EG: Baduanjin/CG: no intervention | 3 | 30–60 | 4 | Lipid parameters: TC↓, TG↓, HDL↑, LDL↓ | No |
EG, experimental group; CG, control group; BP, blood pressure; BMI, body mass index; WHR, waist-to-hip ratio; FPG, fasting plasma glucose; TG, triglycerides; LDL, low-density lipoprotein; HDL, high-density lipoprotein; WC, white cells; TC, total cholesterol; HbA1c, hemoglobin A1c